Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study.
Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC, Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, AlMahameed A, Abdel-Latif A, Tang WH, Brennan D, McErlean E, Hazen SL, Topol EJ. Bhatt DL, et al. Among authors: corbelli jc. Am Heart J. 2007 Jul;154(1):137-43. doi: 10.1016/j.ahj.2007.03.029. Am Heart J. 2007. PMID: 17584566 Clinical Trial.
Temporal Trends, Complications, and Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Sawant AC, Josey K, Plomondon ME, Maddox TM, Bhardwaj A, Singh V, Rajagopalan B, Said Z, Bhatt DL, Corbelli J. Sawant AC, et al. JACC Cardiovasc Interv. 2017 Jul 10;10(13):1295-1303. doi: 10.1016/j.jcin.2017.03.051. JACC Cardiovasc Interv. 2017. PMID: 28683935 Free article.
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
Tardif JC, Ballantyne CM, Barter P, Dasseux JL, Fayad ZA, Guertin MC, Kastelein JJ, Keyserling C, Klepp H, Koenig W, L'Allier PL, Lespérance J, Lüscher TF, Paolini JF, Tawakol A, Waters DD; Can HDL Infusions Significantly QUicken Atherosclerosis REgression (CHI-SQUARE) Investigators. Tardif JC, et al. Eur Heart J. 2014 Dec 7;35(46):3277-86. doi: 10.1093/eurheartj/ehu171. Epub 2014 Apr 29. Eur Heart J. 2014. PMID: 24780501 Free PMC article. Clinical Trial.
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM; PRESERVE Trial Group. Weisbord SD, et al. N Engl J Med. 2018 Feb 15;378(7):603-614. doi: 10.1056/NEJMoa1710933. Epub 2017 Nov 12. N Engl J Med. 2018. PMID: 29130810 Free article. Clinical Trial.
Compliant vs non-compliant balloons. A prospective randomized study.
Seyithanoglu BY, Zaki Masud AR, Ergene O, Morris WM, Kozan O, Corbelli JC, Wilson MF. Seyithanoglu BY, et al. Among authors: corbelli jc. Jpn Heart J. 1998 Jan;39(1):45-54. doi: 10.1536/ihj.39.45. Jpn Heart J. 1998. PMID: 9601481 Clinical Trial.
Superior safety of direct oral anticoagulants compared to Warfarin in patients with atrial fibrillation and underlying cancer: a national veterans affairs database study.
Sawant AC, Kumar A, Mccray W, Tetewsky S, Parone L, Sridhara S, Prakash MPH, Tse G, Liu T, Kanwar N, Bhardwaj A, Khan S, Manion C, Lahoti A, Pershad A, Elkin P, Corbelli J. Sawant AC, et al. J Geriatr Cardiol. 2019 Sep;16(9):706-709. doi: 10.11909/j.issn.1671-5411.2019.09.006. J Geriatr Cardiol. 2019. PMID: 31645857 Free PMC article.
34 results